Your browser doesn't support javascript.
loading
Obstructive sleep apnea severity and prevalent atrial fibrillation in a sleep clinic cohort with versus without excessive daytime sleepiness.
Holtstrand Hjälm, Henrik; Thunström, Erik; Glantz, Helena; Karlsson, Martin; Celik, Yeliz; Peker, Yüksel.
Afiliación
  • Holtstrand Hjälm H; Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: henrik.holtstrand.hjalm@vgregion.se.
  • Thunström E; Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Glantz H; Department of Internal Medicine, Skaraborg Hospital, Lidköping, Sweden.
  • Karlsson M; Department of Internal Medicine, Skaraborg Hospital, Lidköping, Sweden.
  • Celik Y; Department of Pulmonary Medicine, Koc University School of Medicine & Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
  • Peker Y; Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Pulmonary Medicine, Koc University School of Medicine & Koc University Research Center for Translational Medicine (KUTTAM), Istanbul,
Sleep Med ; 112: 63-69, 2023 12.
Article en En | MEDLINE | ID: mdl-37806037
ABSTRACT

BACKGROUND:

Obstructive sleep apnea (OSA) is associated with atrial fibrillation (AF) in cardiac cohorts. Less is known regarding the magnitude of this association in a sleep clinic cohort with vs. without excessive daytime sleepiness (EDS).

OBJECTIVES:

To explore the association of OSA severity with AF in a sleep clinic cohort stratified by EDS. PATIENTS AND

METHODS:

All consecutive adults (n = 3814) admitted to the Skaraborg Hospital, Sweden between Jan 2005 and December 2011 were registered in a local database, and the follow-up ended in December 2018. OSA was defined as an apnea-hypopnea index (AHI) ≥5 events/h. Mild OSA was defined as AHI ≥5 & AHI<15 events/h; moderate OSA as AHI ≥15 & AHI<30 events/h; and severe OSA as AHI ≥30 events/h. EDS was defined as an Epworth Sleepiness Scale score ≥11. We conducted cross-sectional analyzes of the prevalent AF across the OSA severity categories and logistic regression analyzes stratified by EDS.

RESULTS:

In all, 202 patients (5.3%) had AF at baseline, 1.6% in no-OSA, 3.9% in mild OSA, 5.2% in moderate OSA, and 7.6% in severe OSA, respectively (p < 0.001). The stratified analyzes revealed that patients with severe OSA without EDS had an increased risk for prevalent AF (OR 2.54, 95% CI 1.05-6.16; p = 0.039) independent of the confounding factors.

CONCLUSIONS:

There was an independent dose-response relationship between OSA and prevalent AF among the non-sleepy phenotype in this sleep clinic cohort. Since adherence to OSA treatment is challenging in the absence of EDS, these patients may have increased risk for adverse cardiovascular outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Apnea Obstructiva del Sueño / Trastornos de Somnolencia Excesiva Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Sleep Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Apnea Obstructiva del Sueño / Trastornos de Somnolencia Excesiva Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Sleep Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2023 Tipo del documento: Article